“…The ability to taper glaucoma medications was another observed benefit. 27 Factors toward success were higher baseline IOP, 19,28-30 pseudoexfoliation, 19,28 black race, 27,31 older age, 19,31 male gender, 32 pseudophakic lens status (versus aphakia), 33 number of pre-laser medications, 34 increased pigmentation, 35 number of treatment spots, 35,36 and treatment in the inferior angle. 27 Parameters such as age and refraction 29 were found to be insignificant.…”